Production (Stage)
Kewaunee Scientific Corporation
KEQU
$58.45
-$0.69-1.17%
NASDAQ
| 04/30/2025 | 01/31/2025 | 10/31/2024 | 07/31/2024 | 04/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 36.06% | 43.59% | -5.30% | -2.90% | 5.03% |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 36.06% | 43.59% | -5.30% | -2.90% | 5.03% |
| Cost of Revenue | 26.27% | 40.40% | -8.54% | -5.33% | -3.58% |
| Gross Profit | 64.19% | 52.79% | 3.59% | 4.82% | 41.30% |
| SG&A Expenses | 70.41% | 95.17% | 13.32% | 21.68% | 18.75% |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 34.13% | 50.92% | -4.49% | -0.55% | -0.24% |
| Operating Income | 53.93% | -40.24% | -12.53% | -31.64% | 105.81% |
| Income Before Tax | 430.73% | -63.73% | -18.86% | -28.78% | -41.99% |
| Income Tax Expenses | 122.40% | -111.00% | -54.54% | -78.60% | -900.65% |
| Earnings from Continuing Operations | -55.75% | -45.40% | 6.54% | -11.01% | 921.85% |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | 36.60% | -141.67% | 92.86% | -9.76% | -71.91% |
| Net Income | -56.01% | -46.29% | 10.10% | -11.36% | 997.11% |
| EBIT | 53.93% | -40.24% | -12.53% | -31.64% | 105.81% |
| EBITDA | 54.46% | -16.78% | -10.26% | -24.41% | 86.09% |
| EPS Basic | -55.95% | -45.90% | 11.30% | -11.02% | 986.43% |
| Normalized Basic EPS | 36.76% | -64.59% | -15.49% | -29.26% | 132.63% |
| EPS Diluted | -56.06% | -47.06% | 8.60% | -13.95% | 1,008.22% |
| Normalized Diluted EPS | 36.15% | -65.21% | -17.60% | -31.49% | 131.51% |
| Average Basic Shares Outstanding | -0.14% | -0.73% | -1.07% | -0.38% | 0.99% |
| Average Diluted Shares Outstanding | 0.30% | 1.01% | 1.47% | 2.84% | 1.50% |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -- | -- | -- | -- | -- |